P

Poltreg SA
WSE:PTG

Watchlist Manager
Poltreg SA
WSE:PTG
Watchlist
Price: 41 PLN 0.74% Market Closed
Market Cap: 191.2m PLN
Have any thoughts about
Poltreg SA?
Write Note

Poltreg SA
Investor Relations

PolTREG SA develops and commercializes patented TREG methods. The company is headquartered in Gdansk, Woj. Pomorskie and currently employs 11 full-time employees. The company went IPO on 2021-11-23. The firm conducts research in the field of autoimmunological diseases. The firm works on a method of healing, that uses t-regulated cells (TREGs). The Firm possesses its own, patented technology to obtain T-regulated lymphocytes, that are used in the therapy. The firm works on therapy for diseases such as type one diabetes, type two diabetes, and multiple sclerosis. In its research, the Company cooperates with multiple specialists from various fields of science. The firm is developing its own research center, which is intended as a basic location for conducting future research activities.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Earnings Calls

No Earnings Calls Available

Management

Mr. Piotr Trzonkowsk
President of the Management Board
No Bio Available
Ms. Kamilla Agnieszka Bok
Director of Operations
No Bio Available
Mr. Mariusz Jablonski
Member of the Management Board
No Bio Available

Contacts

Address
WOJ. POMORSKIE
Gdansk
Waly Piastowskie 1 lok. 1508
Contacts